Page results
-
We have been informed that there has been an increasing number of fractures in the battery securing parts of this pump. During the insulin pump use, if the device is dropped or excessive force is applied, some of the device's battery securing parts may break.
-
Until this point, if a largely over estimated total daily dose was entered by the user incorrectly, there is a risk of over delivery of insulin during Auto mode. This risk is the highest on the first day and reduces gradually over subsequent days.
-
UCLH is reminding staff that gloves are not always required, by reducing the instances where non-sterile plastic gloves are used when treating non-infectious patients. The focus is now on how clean hands are just as effective a barrier against infection.
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
Being diagnosed with cancer can be a difficult time for you and those close to you. This page gives you an overview of the care you can expect to receive as our patient at University College London Hospitals NHS Foundation Trust (UCLH). It also introduces different types of healthcare professionals you may meet along the way.
-
This booklet explains what stem cells are and how they are collected from your blood. It includes information about what happens before, during and after the collection, and how the cells are stored.
File results
-
FOI/2024/0646 - Management of Combine Heat and Power (CHP) units
-
FOI/2024/0647 - Treatment of rare diseases; Fabry/ Gaucher/ Pompe disease
-
FOI/2024/0650 - Framework used for Radiology Information System (RIS)
-
FOI/2024/0653 - Sterile services/ decontamination units
-
FOI/2024/0659 - Treatment of cancers; breast/ prostate/ ovarian and endometrial
-
FOI/2024/0660 - Bariatric patient equipment spend/ contract/ supplier
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0664 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0666 - Non-emergency patient transport services (NEPTS) and pathology specimen courier services
-
FOI/2024/0661 - Maternity services for caesareans